NCT03583216 is a clinical trial of Diabetic pregnancy in Diabetic Pregnancy, sponsored by Acibadem University.

Who is sponsoring NCT03583216?

NCT03583216 is sponsored by Acibadem University.

What drugs are being tested in NCT03583216?

Interventions in NCT03583216: Diabetic pregnancy, Non-diabetic pregnancy.

What condition does NCT03583216 study?

NCT03583216 studies Diabetic Pregnancy, Pregnancy Related, Complement System; Disorder.

Is NCT03583216 still recruiting?

NCT03583216 is currently completed. Last updated 27 December 2018.

Last reviewed 2018-12-27 · How we verify

NCT03583216

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Factor XII Levels in Gestational Diabetic and Healthy Pregnancies

Completed Last updated 27 December 2018

What this trial tests

trial testing Diabetic pregnancy in Diabetic Pregnancy in 60 participants. Completed in 30 November 2018.

Timeline

20 July 2018

Primary endpoint
30 September 2018

30 November 2018

Quick facts

Lead sponsor	Acibadem University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	20 July 2018
Primary completion	30 September 2018
Estimated completion	30 November 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Diabetic pregnancy
Non-diabetic pregnancy

Conditions studied

Diabetic Pregnancy — all drugs for Diabetic Pregnancy →
Pregnancy Related — all drugs for Pregnancy Related →
Complement System; Disorder — all drugs for Complement System; Disorder →

Sponsor

Acibadem University

Who can join

Adults 18 to 50, female only, with Diabetic Pregnancy or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare Factor XII levels in gestational diabetic and healthy pregnancies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of factor XII levels in gestational diabetes, fetal macrosomia, and healthy pregnancies.
Ozbasli E, Takmaz O, Karabuk E, Gungor M. · · 2020 · cited 8× · PMID 33267793 · DOI 10.1186/s12884-020-03455-0

Verify or expand the search:

Other Acibadem University trials

Trials by the same sponsor.

NCT07481864 — The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair. · NA · not yet recruiting
NCT07488377 — Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease · not yet recruiting
NCT07488364 — Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis · not yet recruiting
NCT07488351 — "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life" · not yet recruiting
NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03583216 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Acibadem University
Last refreshed: 27 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03583216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing